CVE-2021-31562 - CVE House
Back to Database
Status published Medium CVE-2021-31562

Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algorithm

Vulnerability Description

The SSL/TLS configuration of Fresenius Kabi Agilia Link + version 3.0 has serious deficiencies that may allow an attacker to compromise SSL/TLS sessions in different ways. An attacker may be able to eavesdrop on transferred data, manipulate data allegedly secured by SSL/TLS, and impersonate an entity to gain access to sensitive information.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2021-31562

Credits & Attribution

The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:

  • Julian Suleder (ERNW Research GmbH), Nils Emmerich (ERNW Research GmbH), Raphael Pavlidis (ERNW Research GmbH), and Dr. Oliver Matula (ERNW Enno Rey Netzwerke GmbH) reported these vulnerabilities to the German Federal Office for Information Security (BSI) in the context of the BSI project ManiMed (Medical Device Manipulation Project).

Affected Vendor

Fresenius Kabi

View all reports →

Affected Software

Agilia Link+
Vulnerable Versions:
unspecified

Timeline

Official Publish: January 21st, 2022
Last Modified: April 16th, 2025
Added to House: July 21st, 2026

CVSS Vectors

V3: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Weaknesses (CWE)